Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Annovis Bio Inc ANVS

Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced... see more

Bullboard (NYSE:ANVS)

View:
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Nov 11, 2024 9:17pm

InvestorNewsBreaks - Annovis Bio Inc. Advances Alzheimer's P

News; $ANVS InvestorNewsBreaks - Annovis Bio Inc. Advances Alzheimer's Phase 3 Trials with Strong FDA Support and Financial BackingAnnovis Bio (NYSE: ANVS) provided a third-quarter update ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Oct 02, 2024 5:00pm

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential F

News; $ANVS Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative CombinationsNEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Aug 06, 2024 2:00am

Trend Tracker for (ANVS)

NEWS: $ANVS Trend Tracker for (ANVS)2024-08-06 01:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Jul 11, 2024 11:32am

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forec

Breaking News: $ANVS Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday | BenzingaTop Wall Street analysts changed their outlook on these top names. For a complete view of ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Jul 08, 2024 4:46pm

US Companies Moving the Markets, Evening edition
Mon, Ju

NEWS: $ANVS US Companies Moving the Markets, Evening edition Mon, Jul 08, 2024 as of 4:00 pm ETA look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 12.5 ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Jun 25, 2024 8:45pm

InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Announces

Breaking News: $ANVS InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Announces Upcoming Investor Webcast Focused on PD, Lead Drug CandidateAnnovis Bio (NYSE: ANVS) , a late-stage, drug ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Jun 11, 2024 7:30pm

InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Announces

Breaking News: $ANVS InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Announces Results of Recent Alzheimer's Study, Schedules Investor CallAnnovis Bio (NYSE: ANVS) , a late-stage ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson Jun 11, 2024 5:00pm

Annovis Bio's Buntanetap Found Safe and Effective in High-Ri

Breaking News: $ANVS Annovis Bio's Buntanetap Found Safe and Effective in High-Risk Alzheimer's PatientsMALVERN, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- via IBN @ Annovis Bio Inc. (NYSE: ANVS)  ...more  
User Avatar Image
(282)
•••
  • whytestocksX
Post by whytestockson May 09, 2024 12:00pm

Annovis Announces Unblinding of the Buntanetap Phase III Dat

JUST IN: $ANVS Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's DiseaseMALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (&#x201C ...more  
Post by mevanion Dec 29, 2021 12:53pm

Anyone buying here?

Looking for the bottom.   
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Jun 22, 2021 8:30am

ANVS 5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!

5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Jun 21, 2021 8:36am

CHEMOCENTRYX: A LOT RIDES ON THE APPROVAL OF AVACOPAN

$CCXI CHEMOCENTRYX: A LOT RIDES ON THE APPROVAL OF AVACOPAN
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Jun 18, 2021 8:24am

CAN ANNOVIS BIO DELIVER A BREAKTHROUGH IN ALZHEIMER’S DISEAS

$ANVS CAN ANNOVIS BIO DELIVER A BREAKTHROUGH IN ALZHEIMER’S DISEASE? https://www.aviseanalytics.com/annovis-bio/
User Avatar Image
(72)
•••
  • IseneschalX
Comment by Iseneschalon May 21, 2021 6:09pm

RE:ANVS......You've all been had ....again!!!!

This was planned out a few months ago....check it out. Here is the link to EDGAR.... EDGAR Entity Landing Page (sec.gov) This chit is done every day....you better do some research before you trade. ...more  
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon May 21, 2021 6:03pm

ANVS......You've all been had ....again!!!!

Annovis Bio, Inc. Announces Proposed Public Offering of Common Stock 2021-05-21 14:16 PT - News Release Berwyn, Pennsylvania--(Newsfile Corp. - May 21, 2021) - Annovis Bio, Inc. (NYSE ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities